Slide 1: FY15 Full Year Results
For personal use only FY 15 Full Year Results 23 September 2015
Slide 2: Vision and Mission Statement
For personal use only Vision and Mission Statement Vision: To optimise the health and development of adults, infants and children. Mission: To deliver science based bioactives which provide health benefits to adults, infants, children and to the medical food markets. 23/09/2015
Slide 3: FY 2015 Results
For personal use only FY 2015 Results AUD million 4E Reported 4E Reported 31 July 2015 31 July 2014 Revenue $29.9 $27.2 Profit before tax nil $1.2 EBITDA $0.6 $1.6 EBIT nil $1.1 Tax $0.1 ($0.3) NPAT $0.1 $1.0 EPS 0.06 cps 0.59 cps ROE (annualised) 0.3% 3.4% 23/09/2015
Slide 4: Balance Sheet July 2015
For personal use only Balance Sheet 31 July 2015 AUD million Reported Reported Movement 31 July 2015 31 July 2014 Cash $9.6 $8.0 1.6 Trade Receivables $5.5 $6.9 1.4 Inventories $14.2 $16.5 2.3 Total Current Assets $29.5 $32.9 3.4 PPE/Intangible $5.0 $4.9 0.1 Assets Total Assets $36.6 $39.5
Slide 5: Cash Flow Year ended July 2015
For personal use only Cash Flow Year ended 31 July 2015 AUD million Reported From Operations 31 July 2015 EBITDA $0.6 Working Capital Movement $2.0 Net Interest $0.1 Tax Received $0.4 Cash Flow from Operations $3.1 Financing Activities ($0.8) Capex ($0.8) Net Cash Flow $1.5 23/09/2015
Slide 6: FY2015 Key Items
For personal use only FY2015 Key Items •10% year on year revenue growth •Recovery of traditional markets and customers and encouraging growth in sales to new customers •Oceania and Asia remain key geographic sales regions •Increased senior sales staff •Continued gross margin pressure, down to 20.2%
Slide 7: Delivery systems based on a variety of nutritional bioactives
Delivery systems based on a variety of For personal use only nutritional bioactives Sales Revenue based on Diversified Bioactives in FY2015 • Product portfolio includes encapsulated powders containing marine oil, algal oils, other specialty oils and important micronutrients 39% • Encapsulation techn
Slide 8: Sales by geography/product
For personal use only Sales by geography/product FY 2015 Geographic • Continued strong presence Australia / New Zealand 40% through Oceania and Asia Asia 44% Europe 8% Americas 8% • Encapsulation technology strong and proven FY 2015 Product Oil 2% Encapsulated Powders 98% 23/09/2015
Slide 9: Growth Objectives
For personal use only Growth Objectives •Continued focus on the infant formula market –Specialist delivery systems –Developing new markets/applications –Improved bioactive protection •Develop medical food program –Product pipeline to improve the health of preterm infants –Major phase 3 clinical tria
Slide 10: FY2016 Outlook & Priorities
For personal use only FY2016 Outlook & Priorities •Continue to work with existing and new customers to gain market share in Asia •Develop new product applications in collaboration with customers •Organic growth with emphasis on Oceania, Asia and Europe •Commercialise first Medical product •Diversify
Slide 11: Disclaimer
For personal use only Disclaimer The release, publication or distribution of this presentation in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this presentation is released, published or distributed should inform themselves about and observe s